NAD+ is an essential cellular coenzyme involved in redox chemistry and energy metabolism. As a substrate for sirtuins, PARPs and CD38, it is researched in mitochondrial regulation, DNA-damage signalling, stress responses and metabolic communication.
Current work examines NAD+ availability and NAD-dependent pathways as mechanistic and translational research questions, not established clinical benefits.
Explore NAD+ researchResearch context only; not a therapeutic claim.GHK-Cu is a copper-binding tripeptide studied in gene-expression, extracellular-matrix, collagen- and elastin-related pathways, cellular migration, copper homeostasis and oxidative-stress responses.
Research also examines skin and tissue-repair mechanisms. Evidence remains primarily laboratory, preclinical or cosmetic and does not establish a therapeutic benefit.
Explore GHK-Cu researchResearch context only; not a therapeutic claim.
Five key research areas Neurotrophic signalling — includes Semax-related BDNF, NGF and neuronal-response research. Stress-response pathways — includes Selank-related nervous-system research. Attention and memory — supports ...
View product
Five key research areas Cellular energy — combines NAD+ and mitochondrial-derived peptide research. Mitochondrial adaptation — includes MOTS-C pathways involved in metabolic stress responses. Redox balance — supports oxidat...
View product
Five key research areas Metabolic receptor research — includes GLP-1, GIP and glucagon-receptor pathways. GHRH signalling — includes tesamorelin and CJC-related growth-hormone-releasing pathways. Ghrelin-receptor signalling...
View product
Five key research areas Multi-receptor metabolism — includes GLP-1, GIP and glucagon-receptor research through retatrutide. Growth-hormone signalling — adds GHRH-receptor research through tesamorelin. Mitochondrial energy —...
View product